Biocompatible shares plunge after chief leaves
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The value of shares in Biocompatible, the healthcare company, plunged by more than 40 per cent yesterday, after it announced that Alistair Taylor had resigned as president and chief executive. A company spokeswoman said he had lost the confidence of the board in his ability to find marketing partners for the company's innovative products. The shares fell 160p to 215p, wiping pounds 11m off its market value.
The board has formed a management committee which will be chaired by Jeremy Curnock Cook, ahead of the appointment of a new chief executive. In a statement the company said: "The management committee will focus on progressing on going discussions with potential commercial partners as well as reviewing the options for independent distribution of the company's stents in some markets."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments